Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lipid reduction without medication. What effect does diet have on lipids?]

Anja Vogt1, Elisabeth Steinhagen-Thiessen

  • 1Interdisziplinäres Stoffwechsel-Centrum, Lipidambulanz/Lipidapherese Med. Fakultät, Humboldt-Universität Berlin Charité, Virchow-Klinikum Augustenburger Platz 1 13353 Berlin. anja.vogt@charite.de

Pharmazie in Unserer Zeit
|December 3, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex- and menopause-specific inverse associations between metabolic dysfunction-associated steatotic liver disease and serum lipoprotein(a) concentrations: evidence from SHIP and UK Biobank.

Cardiovascular diabetology·2026
Same author

Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.

European heart journal·2026
Same author

Correction: Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany.

PloS one·2026
Same author

Lipoprotein apheresis in the era of new lipid-lowering therapies.

European heart journal·2026
Same author

Effects of micro/nanoplastics combined with three anthropogenic chemicals on larval zebrafish (Danio rerio): study of toxicity, behaviour and assessment of uptake.

NanoImpact·2026
Same author

Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial.

European heart journal·2026